AKT1 and breast cancer: In particular, the authors described a missense mutation in PIK3CA (c.3140A>G, p. H1047R), a common activation mutation in breast cancer, enhancing PI3K lipid kinase activity, stimulating the PI3K/AKT signaling pathway and promoting the tumoral invasion and metastasis.